Minneapolis, Minnesota, United States Affinity Capital Management appeared to be the VC, which was created in 1993. The company was established in North America in Minneapolis. The leading representative office of defined VC is situated in the United States.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Arbor Surgical Technologies, NovaSys, Disc Dynamics. The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Internet, Medical Device.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Affinity Capital Management, startups are often financed by Delphi Ventures, Three Arch Partners, Prism Venture Management. The meaningful sponsors for the fund in investment in the same round are ONSET Ventures, Canaan Partners, Prism Venture Management. In the next rounds fund is usually obtained by Polaris Partners, Delphi Ventures, Canaan Partners.
The typical startup value when the investment from Affinity Capital Management is 5-10 millions dollars. The high activity for fund was in 2008. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2013. Comparing to the other companies, this Affinity Capital Management performs on 3 percentage points less the average number of lead investments.
The current fund was established by Edson Spencer. The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anaxago | France, Ile-de-France, Paris |
| ARK Ola Pre IPO Private Investment Trust | - |
| Avala Capital | Berlin, Berlin, Germany |
| Bishop Ranch Intelligence Innovation Accelerator | California, San Ramon, United States |
| Bridge Information Systems | - |
| Centre Capital Developpement | Centre-Loire Valley, France, Orléans |
| Chan Wanich | - |
| CMW Asset Management | China, Guangdong, Shenzhen |
| Coppel Family | - |
| Eagle Seven | Chicago, Illinois, United States |
| eLab Technology Fund | Canada, Ontario, Toronto |
| Huitong Yongxin Touzi | Beijing, Beijing, China |
| Nassau Street Ventures | Boston, Massachusetts, United States |
| NEM Ventures | - |
| Odysseus Investments | Luxembourg, Luxembourg |
| Park West Asset Management | California, Larkspur, United States |
| Privaris | Charlottesville, United States, Virginia |
| Quaker Partners | Pennsylvania, Philadelphia, United States |
| Shanghai Jie Hua Qiche Shijian Fazhan Zhongxin | China, Shanghai |
| Victoria Capital Partners | Argentina, Buenos Aires, Distrito Federal |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ExplORer Surgical | $5M | 18 Apr 2019 | Chicago, Illinois, United States | ||
| $40M | 13 Mar 2012 | Seattle, Washington, United States | |||
Respicardia | $27M | 25 Aug 2010 | Minnesota, United States | ||
| $17M | 07 Jul 2010 | Seattle, Washington, United States | |||
Baxano | $30M | 23 Jun 2010 | San Jose, California, United States | ||
Hemosphere | $9M | 07 Apr 2010 | Georgia, United States | ||
ValenTx | $22M | 08 Sep 2009 | Minnesota, United States | ||
| $6M | 21 Feb 2009 | California, United States | |||
Respicardia | $21M | 17 Oct 2008 | Minnesota, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ExplORer Surgical | $5M | 18 Apr 2019 | Chicago, Illinois, United States | ||
| $40M | 13 Mar 2012 | Seattle, Washington, United States | |||
Respicardia | $27M | 25 Aug 2010 | Minnesota, United States | ||
| $17M | 07 Jul 2010 | Seattle, Washington, United States | |||
Baxano | $30M | 23 Jun 2010 | San Jose, California, United States | ||
Hemosphere | $9M | 07 Apr 2010 | Georgia, United States | ||
ValenTx | $22M | 08 Sep 2009 | Minnesota, United States | ||
| $6M | 21 Feb 2009 | California, United States | |||
Respicardia | $21M | 17 Oct 2008 | Minnesota, United States |
